[1] |
World Health Organization. Rapid communication: TB antigen-based skin tests for the diagnosis of TB infection. Geneva: World Health Organization, 2022.
|
[2] |
Li F, Xu M, Qin C, et al. Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial. Clin Microbiol Infect, 2016, 22(10):889.e9-889.e16. doi:10.1016/j.cmi.2016.07.015.
doi: 10.1016/j.cmi.2016.07.015
URL
|
[3] |
Xu M, Lu W, Li T, et al. Sensitivity, Specificity, and Safety of a Novel ESAT6-CFP10 Skin Test for Tuberculosis Infection in China: 2 Randomized, Self-Controlled, Parallel-Group Phase 2b Trials Clin. Infect Dis, 2022, 74(4):668-677. doi:10.1016/j.cmi.2016.07.015.
doi: 10.1016/j.cmi.2016.07.015
|
[4] |
Du WX, Chen BW, Lu JB, et al. Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein. Med Sci Monit Basic Res, 2013, 19:146-152. doi:10.12659/MSMBR.883912.
doi: 10.12659/MSMBR.883912
|
[5] |
Starshinova A, Zhuravlev V, Dovgaluk I, et al. A comparison of intradermal test with recombinant tuberculosis allergen (diaskintest) with other immunologic tests in the diagnosis of tuberculosis infection. Int J Mycobacteriol, 2018, 7(1):32-39. doi:10.4103/ijmy.ijmy_17_18.
doi: 10.4103/ijmy.ijmy_17_18
pmid: 29516883
|
[6] |
Starshinova A, Dovgalyk I, Malkova A, et al. Recombinant tuberculosis allergen (Diaskintest®) in tuberculosis diagnostic in Russia (meta-analysis). Int J Mycobacteriol, 2020, 9(4):335-346. doi:10.4103/ijmy.ijmy_131_20.
doi: 10.4103/ijmy.ijmy_131_20
pmid: 33323648
|
[7] |
Aggerbeck H, Ruhwald M, Hoff ST, et al. C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial. PLoS One, 2018, 13(9):e0204554. doi:10.1371/journal.pone.0204554.
doi: 10.1371/journal.pone.0204554
|
[8] |
Aggerbeck H, Ruhwald M, Hoff S, et al. Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial. Int J Tuberc Lung Dis, 2019, 23(1):38-44. doi:10.5588/ijtld.18.0137.
doi: 10.5588/ijtld.18.0137
pmid: 30572979
|
[9] |
Hoff ST, Peter JG, Theron G, et al. Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection. Eur Respir J, 2016, 47(3):919-928. doi:10.1183/13993003.01464-2015.
doi: 10.1183/13993003.01464-2015
pmid: 26677940
|
[10] |
Sharma SK, Vashishtha R, Chauhan LS, et al. Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting. PLoS One, 2017, 12(1):e0169539. doi:10.1371/journal.pone.0169539.
doi: 10.1371/journal.pone.0169539
|
[11] |
World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis. Tests for tuberculosis infection. Geneva: World Health Organization, 2022.
|
[12] |
World Health Organization. WHO operational handbook on tuberculosis. Module 3: diagnosis. Tests for tuberculosis infection. Geneva: World Health Organization, 2022.
|
[13] |
徐苗, 罗永艾, 黎友伦, 等. 重组结核分枝杆菌11000蛋白对结核分枝杆菌感染的鉴别作用. 中华结核和呼吸杂志, 2006, 29(11): 762-765.
|
[14] |
陈保文, 徐苗, 徐敬华, 等. 结核分枝杆菌RD1区重组11kD蛋白的克隆表达及效力. 中国生物制品学杂志, 2006, 19(5):468-470. doi:10.3969/j.issn.1004-5503.2006.05.009.
doi: 10.3969/j.issn.1004-5503.2006.05.009
|
[15] |
中华人民共和国国家药典委员会. 中华人民共和国药典. 北京: 中国医药科技出版社, 2020.
|